Vitamin D3 for Life

Live Enlightened

Physiology

Vitamin D and Inflammatory Signalling Across Cell Types: Full Evidence Review

Previous related pageVitamin D and the Timing of Immune Activation and Restraint: Full Evidence ReviewNext related pageParacrine Vitamin D Signalling: Full Study
Study at a glance

How was vitamin D tested in fat cells and immune cells?

This review brings together three experimental studies of vitamin D and inflammation. Researchers mainly added calcitriol, the active form of vitamin D, to human cells grown in the laboratory. They examined fat cells and several immune-cell types. They measured signals inside cells, substances released by cells and some effects on other cells.

Did vitamin D reduce inflammation signals in every cell type?

In fat cells, calcitriol reduced several inflammatory signals and substances. In a separate test, fluid from treated fat cells attracted fewer immune cells. Another study found that some immune-cell types reduced their signalling after vitamin D exposure, while others increased it or showed no similar reduction. The response therefore depended on which cells were tested.

Did giving vitamin D earlier change the immune-cell response?

In one study, vitamin D was present while immune cells called dendritic cells developed. These cells later released more of several inflammatory substances when stimulated. Their fluid also changed a response in another immune-cell type, called T cells. Adding vitamin D only during the later stimulation produced a different pattern. Not every measured substance changed in the same direction.

Do these cell findings show a general benefit against inflammation?

Vitamin D can change inflammatory responses, but these studies do not show a reduction in inflammation in every setting. Laboratory exposure to the active hormone is different from taking a supplement. Some experiments used few donors, and the fat cells came from one donor. A small part of the research involving people was not a controlled treatment trial. These findings do not establish less inflammatory disease, a clinical benefit or a supplement dose.

Read the full article below ↓

Vitamin D can alter inflammatory signalling, but the direction of the response depends on the cell, its developmental state and the timing of exposure. Three experimental studies illustrate this clearly: inflammatory responses fell in cultured adipocytes, differed among human phagocytes, and increased for several cytokines in one dendritic-cell differentiation system. Together, these findings support context-dependent regulation rather than a universal anti-inflammatory effect. Read the companion Vitamin D and Inflammatory Signalling Across Cell Types: Study Summary.

What question does this review answer?

This review examines how active vitamin D changes signalling pathways and how far those changes predict cytokine release or immune-cell behaviour. Its evidence comes from Ding and colleagues’ adipocyte experiments, Kundu and colleagues’ comparison of phagocyte populations, and Sommer and Fabri’s dendritic-cell experiments. These are independent experimental programmes. Repeated measurements, multiple figures and several endpoints within a paper are not additional independent confirmations.

The physiological background is explained in Vitamin D and Inflammatory Signalling. Here, the narrower question is what the experiments actually measured. A signalling protein becoming less phosphorylated, a cell releasing less cytokine and a person developing less inflammatory disease are different outcomes. The papers can connect some of the first two steps under controlled conditions. They do not establish the last step.

The distinction between exposure to calcitriol, the active hormone, and a person’s circulating vitamin D status is also essential. Adding a defined concentration directly to a culture bypasses absorption, distribution, metabolism and feedback control. These experiments therefore investigate cellular responsiveness. They cannot identify an effective nutritional dose or a blood concentration that would reproduce the culture result.

Adipocytes exposed to macrophage signals

Ding and colleagues studied cultured human adipocytes exposed to medium previously conditioned by macrophages derived from the THP-1 cell line. The adipocytes originated from one female donor. This arrangement models communication between inflammatory cells and fat cells; it does not recreate all the cellular, vascular or metabolic features of human adipose tissue.

The researchers pretreated the adipocytes with calcitriol for 48 hours, using concentrations of 10⁻¹¹ or 10⁻⁸ mol/L, before adding macrophage-conditioned medium. They measured gene expression and later secretion of inflammatory mediators. They also examined proteins associated with NF-κB and mitogen-activated protein kinase signalling. The experimental concentrations and schedules describe laboratory methods, not supplementation instructions.

Macrophage-conditioned medium increased inflammatory responses in the adipocytes. Calcitriol pretreatment reduced expression or release of several mediators, including IL-6, IL-8, MCP-1 and RANTES. The last two are chemokines: their importance in this experiment lies partly in the recruitment of other cells. The broader relationship between inflammatory mediator profiles and immune activity is considered in Vitamin D and Cytokine Balance.

The signalling measurements were consistent with reduced activation of selected pathways. The investigators reported changes involving IκBα and reduced phosphorylation of p65, p38 and ERK. NF-κB and MAPK-related measurements therefore moved alongside the inflammatory outputs. This is useful mechanistic alignment, but it does not demonstrate that one measured protein change was necessary for every subsequent effect.

That distinction matters because the study did not use receptor deletion or a pathway-rescue experiment to establish the full causal sequence. If a treatment changes several processes at once, simultaneous changes can be consistent with a mechanism without proving the order of its steps. Vitamin D Signalling Pathways provides background on vitamin D signalling; the present paper supports a more limited claim about observed pathway responses in this particular culture system.

Did the adipocyte changes affect another cell?

The researchers also tested migration of monocytes towards adipocyte-conditioned medium. In a separate basal conditioned-medium experiment, medium from calcitriol-treated adipocytes attracted fewer migrating cells. This assay did not establish that migration was reduced specifically after macrophage-conditioned inflammatory stimulation. At the higher calcitriol concentration, the reduction was approximately one fifth. This extends the evidence beyond a list of molecular markers: a cellular behaviour relevant to inflammatory recruitment changed as well.

Nevertheless, a migration chamber is not an inflamed tissue. It does not show whether fewer immune cells would enter human adipose tissue, whether inflammation would remain lower over time, or whether insulin sensitivity would improve. Those are separate questions requiring different measurements. The paper did not establish a clinical metabolic benefit.

The single-donor origin of the adipocytes is an important boundary. Replicate wells and repeated experiments improve confidence that an effect can be observed in that preparation. They do not estimate variation among many people. The THP-1-derived macrophage model also adds a specific experimental context. These limits restrict generalisation without making the observed response uninformative.

Some methodological descriptions and figure captions are not perfectly aligned, including aspects of exposure timing and signalling presentation. For that reason, the safest interpretation emphasises the coherent direction of the measured responses rather than a highly precise reconstruction of every intermediate step. The main conclusion remains that calcitriol altered inflammatory signalling, mediator production and migration-related activity in this model.

Phagocytes did not all respond in the same direction

Kundu and colleagues directly addressed a major generalisation problem: would vitamin D exposure suppress inflammatory signalling across different phagocyte populations? They examined cultured monocyte-derived dendritic cells and macrophages, as well as primary blood-cell populations. These cells share some immune functions but are not interchangeable biological systems.

In the monocyte-derived dendritic-cell experiments, cells differentiated for four days with 100 nmol/L calcitriol showed reduced activation of selected signalling responses after stimulation. NF-κB and p38 measurements supported attenuation in that setting. The transcriptomic response to lipopolysaccharide was also broadly reduced. This offers a second example in which vitamin D exposure was associated with restrained inflammatory signalling.

However, cytokine results did not simply mirror a blanket reduction in every pathway. Basal TNF expression was lower, but stimulated TNF and IL-1β responses were preserved, while IL-6 showed a more modest reduction. A broad shift in a transcriptional response and a selective change in a particular cytokine are compatible findings. Neither justifies describing the entire cell as uniformly switched off.

The macrophage and primary-cell comparisons strengthened this caution. NF-κB attenuation did not generalise to the cultured macrophages. In primary blood monocytes, the researchers observed increased NF-κB and p38 responses under the studied conditions, whereas primary dendritic cells showed reduced NF-κB activation. Cell identity therefore changed the direction of the observed response, not merely its size.

This is why Vitamin D and Immune Modulation is a more appropriate physiological framing than a simple claim of immune suppression. Modulation can include restraint of one response while preserving or increasing another. The study’s small donor samples also matter: large numbers of imaged cells do not substitute for large numbers of independent donors. Cell-level precision and population-level certainty are different strengths.

What did the small human component contribute?

Kundu and colleagues also examined blood responses before and after physician-directed supplementation in a small, non-randomised clinical component. This was not a controlled trial showing that supplementation reduces inflammatory disease. Treatment, baseline status and changes over time could not be separated as confidently as they could in a large randomised comparison.

Among the severely deficient subgroup, the reported change in monocyte p38 responsiveness was upward rather than downward. Comparable evidence of a change in NF-κB was not established, and the broader insufficient group did not show the same clear pattern. Baseline associations were also not a simple demonstration that lower vitamin D meant greater pathway activation.

The value of this component is therefore chiefly as a boundary on universal claims. It does not establish that increased monocyte signalling is harmful, beneficial or clinically important. It shows why a direction observed in one cultured cell population should not automatically be projected onto every blood-cell response in a person.

Dendritic-cell development changed cytokine output

Sommer and Fabri explored another source of context: whether vitamin D was present while monocytes developed into dendritic cells, during later stimulation, or during both phases. Their six-day differentiation cultures used 10 nmol/L calcitriol or, in a separate condition, 100 nmol/L 25-hydroxyvitamin D; the principal stimulation used the TLR2/1 ligand Pam3Cys. Exposure history was part of the intervention, not a minor procedural detail.

When calcitriol was present during differentiation, the resulting dendritic cells released more of several inflammatory cytokines following stimulation. These included TNF, IL-6, IL-1β, IL-12p40 and IL-23. The pattern was not a uniform increase in every measured mediator: IL-10, TGF-β and IL-12p70 did not show the same response. IL-12p40 is a shared subunit measurement and must not be treated as equivalent to bioactive IL-12p70.

At the same time, surface-marker changes included lower HLA-DR, CD80 and CD1a and higher ILT3 and PD-L1. Some of these changes can appear compatible with a regulatory phenotype. Yet the secreted cytokine results were more inflammatory for several measured outputs. A label based only on surface markers would therefore miss material evidence about what the cells released.

Exposure during stimulation alone produced a different pattern, including reductions in IL-1β and IL-10. Timing altered the result. This provides a concrete example of why “vitamin D increases anti-inflammatory cytokines” is too broad: even a cytokine commonly described as anti-inflammatory did not move in a consistently upward direction across the experimental conditions.

From dendritic-cell products to T-cell responses

The researchers went beyond dendritic-cell measurements by exposing activated T cells to the resulting culture supernatants. Supernatant from dendritic cells differentiated with vitamin D increased the subsequent IL-22 response. This was a functional connection between the products of one cell population and the behaviour of another.

Blocking experiments implicated contributions from TNF, IL-6-related signalling and a p40-containing cytokine pathway. The p40 intervention could not uniquely separate IL-23 from IL-12-related effects. The result therefore supports a multi-cytokine contribution without proving that a single mediator explains the entire response.

The study also illustrates why assay definitions matter. Cytokine concentration in a supernatant and the proportion of cytokine-positive cells are different measurements. Secreted interferon-γ did not change significantly, whereas the proportion of interferon-γ-positive T cells increased from about 24.2% to 30% (P < 0.05). The secretion experiment included 13 donors and the cytokine-positive-cell analysis 11. Treating them as interchangeable would erase information about how the response was measured.

This local exchange is relevant to Vitamin D and Paracrine Signalling, where signals from one nearby cell influence another. It does not demonstrate that circulating cytokines changed, that whole-body inflammation improved, or that an inflammatory disease was prevented. IL-22 itself cannot be assigned a universal clinical meaning from this experiment alone.

Why the studies should not be flattened into one answer

Kundu and Sommer both studied dendritic-cell-related responses, yet their findings are not interchangeable replications. Their differentiation conditions, exposures, stimulation protocols and endpoints differed. Those differences may help explain divergent findings, but the studies do not isolate a single protocol feature that conclusively resolves the disagreement.

The appropriate synthesis preserves the divergence: some pathway responses were attenuated in one system, while several stimulated cytokine outputs increased in another. A selected positive result from one paper cannot cancel the qualifying result from the other. Why Vitamin D Results Differ explains the wider problem of interpreting findings obtained in different biological and experimental settings.

The distinction also applies to related processes such as Vitamin D and Oxidative Stress. Inflammatory signalling and oxidative stress can be investigated together, but these papers do not establish that an unmeasured redox mechanism caused every cytokine change. A plausible neighbouring pathway should not be inserted into the causal chain merely because it is biologically relevant.

Conclusion

The three studies support a precise conclusion: vitamin D exposure can alter inflammatory signalling and downstream cellular behaviour, but its effects depend on the cell population and exposure context. Ding’s adipocyte model links reduced signalling and mediator output with reduced migration-related activity. Kundu demonstrates that suppression does not generalise across phagocytes. Sommer and Fabri show that differentiation-stage exposure can increase several cytokine responses and influence T-cell IL-22 production.

These findings establish experimental responsiveness, not a universal anti-inflammatory action or a clinical treatment effect. Their strongest contribution is to show which distinctions must be retained when moving from molecular signalling to physiological interpretation.

This page is an original Vitamin D3 For Life explanation and critical appraisal of the research cited below.

Primary source and publication details

Related reading

Original sources

Source

1,25-dihydroxyvitamin D3 Protects against Macrophage-Induced Activation of NFκB and MAPK Signalling and Chemokine Release in Human Adipocytes

This study investigated the effects of vitamin D3 on macrophage-elicited inflammatory responses in cultured human adipocytes, particularly the signalling pathways involved.

Publication details

1,25-dihydroxyvitamin D3 Protects against Macrophage-Induced Activation of NFκB and MAPK Signalling and Chemokine Release in Human Adipocytes. Cherlyn Ding, John P H Wilding, Chen Bing. PLoS ONE; 2013; 8; 4; e 61707. DOI: 10.1371/journal.pone.0061707. CC BY. This page provides an original explanatory appraisal; no source figures are reproduced.

Read more →
Source

Cell‐type‐specific modulation of innate immune signalling by vitamin D in human mononuclear phagocytes

Vitamin D is widely reported to inhibit innate immune signalling and dendritic cell (DC) maturation as a potential immunoregulatory mechanism.

Publication details

Cell‐type‐specific modulation of innate immune signalling by vitamin D in human mononuclear phagocytes. Rhiannon Kundu, Aikaterini Theodoraki, Carolin T Haas, Yanjing Zhang, Benjamin Chain, Janos Kriston‐Vizi, Mahdad Noursadeghi, Bernard Khoo. Immunology; 2017; 150; 1; 55 to 63. DOI: 10.1111/imm.12669. CC BY. This page provides an original explanatory appraisal; no source figures are reproduced.

Read more →
Source

Vitamin D Regulates Cytokine Patterns Secreted by Dendritic Cells to Promote Differentiation of IL-22-Producing T Cells

Vitamin D Regulates Cytokine Patterns Secreted by Dendritic Cells to Promote Differentiation of IL-22-Producing T Cells.

Publication details

Vitamin D Regulates Cytokine Patterns Secreted by Dendritic Cells to Promote Differentiation of IL-22-Producing T Cells. Andrea Sommer, Mario Fabri. PLoS ONE; 2015; 10; 6; e 0130395. DOI: 10.1371/journal.pone.0130395. CC BY. This page provides an original explanatory appraisal; no source figures are reproduced.

Read more →